Probing substrate binding to Metallo-β-Lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesis
暂无分享,去创建一个
Gopal R Periyannan | Michael W Crowder | A. Carenbauer | Anne L Carenbauer | James D Garrity | Gopal Periyannan | Robert B Yates | M. Crowder | R. Yates | Anne Carenbauer
[1] D. Payne,et al. Inhibition of metallo-beta-lactamases by a series of mercaptoacetic acid thiol ester derivatives , 1997, Antimicrobial agents and chemotherapy.
[2] S. Levy,et al. The challenge of antibiotic resistance. , 1998, Scientific American.
[3] B. Sutton,et al. Crystal structure of the zinc-dependent beta-lactamase from Bacillus cereus at 1.9 A resolution: binuclear active site with features of a mononuclear enzyme. , 1998, Biochemistry.
[4] A. Carfi. The 3-D structure of a zinc metallo-β-lactarnase from Bacillus cereus reveals a new type of protein fold , 1995 .
[5] D. Payne,et al. Inhibition of metallo-beta-lactamases by a series of thiol ester derivatives of mercaptophenylacetic acid. , 1997, FEMS microbiology letters.
[6] G. Eliopoulos,et al. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] J. Frère,et al. Interaction between class B β‐lactamases and suicide substrates of active‐site serine β‐lactamases , 1999 .
[8] Moreno Galleni,et al. Standard Numbering Scheme for Class B β-Lactamases , 2001, Antimicrobial Agents and Chemotherapy.
[9] G. Wright,et al. Resisting resistance: new chemical strategies for battling superbugs. , 2000, Chemistry & biology.
[10] Cricco Ja,et al. Class B beta-lactamases: the importance of being metallic. , 1999 .
[11] J. Frère,et al. Purification, crystallization and preliminary X-ray analysis of Bacteroides fragilis Zn2+ beta-lactamase. , 1997, Acta crystallographica. Section D, Biological crystallography.
[12] R. Ambler,et al. The structure of beta-lactamases. , 1980, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[13] L. Rice,et al. β -Lactamases: which ones are clinically important? , 2000 .
[14] M. Gilpin,et al. Isolation and structure determination of two novel phenazines from a Streptomyces with inhibitory activity against metallo-enzymes, including metallo-β-lactamase , 1995 .
[15] K. Bush,et al. Carbapenem-hydrolyzing beta-lactamases , 1997, Antimicrobial agents and chemotherapy.
[16] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[17] I. Taylor,et al. The crystal structure of the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia at 1.7 A resolution. , 1998, Journal of molecular biology.
[18] J. Burke,et al. Risk Factors for Epidemic Xanthomonas Maltophilia Infection/Colonization in Intensive Care Unit Patients , 1992, Infection Control & Hospital Epidemiology.
[19] B. Schable,et al. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. , 1990, Reviews of infectious diseases.
[20] C. Makaroff,et al. Arabidopsis Glyoxalase II Contains a Zinc/Iron Binuclear Metal Center That Is Essential for Substrate Binding and Catalysis* 210 , 2001, The Journal of Biological Chemistry.
[21] C. Brooks,et al. Modeling of the metallo‐β‐lactamase from B. fragilis: Structural and dynamic effects of inhibitor binding , 2001, Proteins.
[22] P. Fitzgerald,et al. Unanticipated inhibition of the metallo-beta-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES): a crystallographic study at 1.85-A resolution. , 1998, Biochemistry.
[23] J. Burke,et al. Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. , 1992 .
[24] J. Williams,et al. -Lactamases and -lactamase inhibitors , 1999 .
[25] D. Vanderwall,et al. Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase. , 1998, Chemistry & biology.
[26] C. Pace,et al. How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.
[27] D. Payne,et al. beta-lactamase epidemiology and the utility of established and novel beta-lactamase inhibitors , 2000, Expert opinion on investigational drugs.
[28] K. Bush. Characterization of beta-lactamases , 1989, Antimicrobial Agents and Chemotherapy.
[29] H. Mett,et al. Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants. , 1988, Reviews of infectious diseases.
[30] J. Frère,et al. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. , 2000, Biochemistry.
[31] D. Vanderwall,et al. Structure-activity relationships of biphenyl tetrazoles as metallo-β-lactamase inhibitors , 1999 .
[32] M. Crowder,et al. Inhibition studies on the metallo-beta-lactamase L1 from Stenotrophomonas maltophilia. , 1999, Archives of biochemistry and biophysics.
[33] Gopal R Periyannan,et al. The problem of a solvent exposable disulfide when preparing Co(II)-substituted metallo-β-lactamase L1 from Stenotrophomonas maltophilia , 2000, JBIC Journal of Biological Inorganic Chemistry.
[34] T. Walsh,et al. Overexpression, Purification, and Characterization of the Cloned Metallo-β-Lactamase L1 fromStenotrophomonas maltophilia , 1998, Antimicrobial Agents and Chemotherapy.
[35] Rie Nagano,et al. Carbapenem Derivatives as Potential Inhibitors of Various β-Lactamases, Including Class B Metallo-β-Lactamases , 1999, Antimicrobial Agents and Chemotherapy.
[36] M. Crowder,et al. Kinetic mechanism of metallo-beta-lactamase L1 from Stenotrophomonas maltophilia. , 1999, Biochemistry.
[37] N. Sharma,et al. Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-β-lactamase* , 2001, The Journal of Biological Chemistry.
[38] M. Page. The Mechanisms of Reactions of β-Lactam Antibiotics , 1984 .
[39] O. Herzberg,et al. Crystal structure of the wide-spectrum binuclear zinc β-lactamase from Bacteroides fragilis , 1996 .
[40] Stephen J. Benkovic,et al. Metallo-β-lactamase: structure and mechanism , 1999 .
[41] E. Ceccarelli,et al. Metallo-β-lactamases: does it take two to tango? , 1999 .
[42] K. Bush,et al. Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4 , 1989, Antimicrobial Agents and Chemotherapy.
[43] O. Herzberg,et al. Crystal structures of the cadmium‐ and mercury‐substituted metallo‐β‐lactamase from Bacteroides fragilis , 1997, Protein science : a publication of the Protein Society.
[44] Timothy R. Walsh,et al. Sequence analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia , 1994 .
[45] M. Galleni,et al. Interactions of biapenem with active-site serine and metallo-beta-lactamases , 1995, Antimicrobial agents and chemotherapy.
[46] Bernstein Nj,et al. On the importance of a methyl group in beta-lactamase evolution: free energy profiles and molecular modeling. , 1999 .
[47] B. Shoichet,et al. Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases. , 2001, Chemistry & biology.
[48] J. Knowles. Penicillin resistance: the chemistry of .beta.-lactamase inhibition , 1985 .
[49] W C Johnson,et al. Analysis of protein circular dichroism spectra for secondary structure using a simple matrix multiplication. , 1986, Analytical biochemistry.
[50] S. Mobashery,et al. Critical hydrogen bonding by serine 235 for cephalosporinase activity of TEM-1 beta-lactamase , 1993, Antimicrobial Agents and Chemotherapy.
[51] S. Mobashery,et al. Elucidation of the role of arginine-244 in the turnover processes of class A beta-lactamases. , 1992, Biochemistry.
[52] K. Bush,et al. How β-Lactamases Have Driven Pharmaceutical Drug Discovery , 1998 .
[53] K. Bush,et al. Metallo-β-Lactamases: A Class Apart , 1998 .
[54] S. Ho,et al. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.
[55] Dimas Suárez,et al. Zinc Metallo-β-Lactamase from Bacteroides fragilis: A Quantum Chemical Study on Model Systems of the Active Site , 2000 .
[56] H. Dyson,et al. NMR characterization of the metallo-beta-lactamase from Bacteroides fragilis and its interaction with a tight-binding inhibitor: role of an active-site loop. , 1999, Biochemistry.
[57] K. Bush,et al. Classification of beta-lactamases: groups 1, 2a, 2b, and 2b' , 1989, Antimicrobial Agents and Chemotherapy.
[58] Y. Arakawa,et al. Convenient Test for Screening Metallo-β-Lactamase-Producing Gram-Negative Bacteria by Using Thiol Compounds , 2000, Journal of Clinical Microbiology.
[59] K M Merz,et al. Molecular dynamics simulations of the mononuclear zinc-beta-lactamase from Bacillus cereus. , 2001, Journal of the American Chemical Society.
[60] D. Payne,et al. Metallo-beta-lactamases--a new therapeutic challenge. , 1993, Journal of medical microbiology.
[61] V. Yu,et al. Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. , 1987, Archives of internal medicine.
[62] G. Jacoby,et al. A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.
[63] A. Peracchi,et al. Enzyme catalysis: removing chemically 'essential' residues by site-directed mutagenesis. , 2001, Trends in biochemical sciences.
[64] J. Frère,et al. The beta-lactamase cycle: a tale of selective pressure and bacterial ingenuity. , 1999, Natural product reports.
[65] A. Clarke,et al. Novel Mechanism of Hydrolysis of Therapeutic β-Lactams byStenotrophomonas maltophilia L1 Metallo-β-lactamase* , 2001, The Journal of Biological Chemistry.
[66] J. Frère,et al. The 3‐D structure of a zinc metallo‐beta‐lactamase from Bacillus cereus reveals a new type of protein fold. , 1995 .
[67] M. Crowder,et al. Mutational Analysis of Metallo-β-lactamase CcrA from Bacteroides fragilis† , 2000 .
[68] M. Page,et al. The mechanisms of reactions of .beta.-lactam antibiotics , 1984 .